SCM
PFE icon

Sarissa Capital Management’s Pfizer PFE Stock Holding History

Sarissa Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-432,140
Closed -$12.6M – 18
2013
Q4 		$12.6M Buy
+432,140
New +$12.6M 4.7% 9

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sarissa Capital Management's PFE Position: Q1 2014 in Review

Sarissa Capital Management sold out of Pfizer (PFE) in Q1 2014, closing a stake of 432,140 shares — an estimated $12.6M sold.

Sarissa Capital Management first reported a position in PFE in Q4 2013 and held it in 1 quarter. The position peaked at $12.6M in Q4 2013. 1,781 funds tracked by Wall St. Rank hold PFE as of Q1 2014.

  • Sarissa Capital Management reported no remaining Pfizer position as of Q1 2014 after selling out during the quarter.
  • Sarissa Capital Management sold 432,140 Pfizer shares in Q1 2014, an estimated $12.6M.
  • Sarissa Capital Management first reported a position in Pfizer in Q4 2013 and held it in 1 quarter.
  • Sarissa Capital Management's Pfizer position peaked at $12.6M in Q4 2013.
  • 1,781 funds tracked by Wall St. Rank held Pfizer as of Q1 2014.

Based on Sarissa Capital Management's 13F filing for Q1 2014, filed 15 May 2014.